Relevance of α-defensins (HNP1-3) and defensin β-1 in diabetes

World Journal of Gastroenterology

Volumn , Issue 27, 2014, Pages 9128-9137

  Németh, Balázs Csaba ^a,b   Várkonyi, Tamás ^a   Somogyvári, Ferenc ^a   Lengyel, Csaba ^a   Fehértemplomi, Katalin ^a   Nyiraty, Szabolcs ^a   Kempler, Péter ^a   Mándi, Yvette ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Copy number polymorphism; Diabetes; HNP1 3; Single nucleotide polymorphism; defensins; defensin 1

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN 1; HEMOGLOBIN A1C; MESSENGER RNA; BETA DEFENSIN; DEFB1 PROTEIN, HUMAN; HUMAN NEUTROPHIL PEPTIDE 1; HUMAN NEUTROPHIL PEPTIDE 3;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; COPY NUMBER VARIATION; DEFA1 GENE; DEFA3 GENE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DNA ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; PHENOTYPE; PROMOTER REGION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; ALPHA-DEFENSINS; BETA-DEFENSINS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER;

EID: 84905393679     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i27.9128     Document Type: Article

References (35)

1. Ganz T . Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-720 [PMID: 12949495 DOI: 10.1038/nri1180]
2. Chen H, Xu Z, Peng L, Fang X, Yin X, Xu N, Cen P. Recent advances in the research and development of human defensins. Peptides 2006; 27: 931-940 [PMID: 16226346 DOI: 10.1016/j.peptides.2005.08.018]
3. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 2005; 17: 359-365 [PMID: 15955682 DOI: 10.1016/j.coi.2005.06.002]
4. Bowdish DM, Davidson DJ, Hancock RE. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci 2005; 6: 35-51 [PMID: 15638767 DOI: 10.2174/1389203053027494]
5. Chertov O, Yang D, Howard OM, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000; 177: 68-78 [PMID: 11138786 DOI: 10.1034/j.1600-065X.2000.17702.x]
6. Yang D, Biragyn A, Kwak LW, Oppenheim JJ. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 2002; 23: 291-296 [PMID: 12072367 DOI: 10.1016/s1471-4906(02)02246-9]
7. Quinn K, Henriques M, Parker T, Slutsky AS, Zhang H. Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. Am J Physiol Heart Circ Physiol 2008; 295: H1817-H1824 [PMID: 18805897 DOI: 10.1152/ajpheart.00472.2008]
8. Ganz T. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun 1987; 55: 568-571 [PMID: 3643886]
9. Papayannopoulos V, Zychlinsky A. NETs: a new strategy for using old weapons. Trends Immunol 2009; 30: 513-521 [PMID: 19699684 DOI: 10.1016/j.it.2009.07.011]
10. Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J. Human beta-defensins. Cell Mol Life Sci 2006; 63: 1294-1313 [PMID: 16710608 DOI: 10.1007/s00018-005-5540-2]
11. Dürr M, Peschel A. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 2002; 70: 6515-6517 [PMID: 12438319 DOI: 10.1128/iai.70.12.6515-6517.2002]
12. Boman HG. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 2003; 254: 197-215 [PMID: 12930229 DOI: 10.1046/j.1365-2796.2003.01228.x]
13. De Smet K, Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 2005; 27: 1337-1347 [PMID: 16215847 DOI: 10.1007/s10529-005-0936-5]
14. Zhao C, Wang I, Lehrer RI. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396: 319-322 [PMID: 8915011 DOI: 10.1016/0014-5793(96)01123-4]
15. Schnapp D, Reid CJ, Harris A. Localization of expression of human beta defensin-1 in the pancreas and kidney. J Pathol 1998; 186: 99-103 [PMID: 9875146]
16. Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 2002; 106: 517-525 [PMID: 12153515 DOI: 10.1046/j.1365-2567.2002.01430.x]
17. Hollox EJ, Barber JC, Brookes AJ, Armour JA. Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. Genome Res 2008; 18: 1686-1697 [PMID: 18974263 DOI: 10.1101/gr.080945.108]
18. Dörk T, Stuhrmann M. Polymorphisms of the human beta-defensin- 1 gene. Mol Cell Probes 1998; 12: 171-173 [PMID: 9664579 DOI: 10.1006/mcpr.1998.0165]
19. Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006; 66: 8542-8549 [PMID: 16951166 DOI: 10.1158/0008-5472.can-06-0294]
20. Linzmeier RM, Ganz T. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics 2005; 86: 423-430 [PMID: 16039093 DOI: 10.1016/j.ygeno.2005.06.003]
21. Selsted ME, Ouellette AJ. Mammalian defensins in the antimicrobial immune response. Nat Immunol 2005; 6: 551-557 [PMID: 15908936 DOI: 10.1038/ni1206]
22. Aldred PM, Hollox EJ, Armour JA. Copy number polymorphism and expression level variation of the human alphadefensin genes DEFA1 and DEFA3. Hum Mol Genet 2005; 14: 2045-2052 [PMID: 15944200 DOI: 10.1093/hmg/ddi209]
23. Froy O, Hananel A, Chapnik N, Madar Z. Differential effect of insulin treatment on decreased levels of beta-defensins and Toll-like receptors in diabetic rats. Mol Immunol 2007; 44: 796-802 [PMID: 16740310 DOI: 10.1016/j.molimm.2006.04.009]
24. Barnea M, Madar Z, Froy O. Glucose and insulin are needed for optimal defensin expression in human cell lines. Biochem Biophys Res Commun 2008; 367: 452-456 [PMID: 18178160 DOI: 10.1016/j.bbrc.2007.12.158]
25. Guimarães RL, Segat L, Rocha CR, Brandão LA, Zanin V, Araujo J, Naslavsky MS, de Lima Filho JL, Crovella S. Functional polymorphisms of DEFB1 gene in type 1 diabetes Brazilian children. Autoimmunity 2009; 42: 406-413 [PMID: 19811257]
26. Saraheimo M, Forsblom C, Pettersson-Fernholm K, Flyvbjerg A, Groop PH, Frystyk J. Increased levels of alphadefensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy. Nephrol Dial Transplant 2008; 23: 914-918 [PMID: 18003664 DOI: 10.1093/ndt/gfm711]
27. Joseph G, Tarnow L, Astrup AS, Hansen TK, Parving HH, Flyvbjerg A, Frystyk J. Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients. J Clin Endocrinol Metab 2008; 93: 1470-1475 [PMID: 18211979 DOI: 10.1210/jc.2007-1910]
28. Chen Q, Hakimi M, Wu S, Jin Y, Cheng B, Wang H, Xie G, Ganz T, Linzmeier RM, Fang X. Increased genomic copy number of DEFA1/DEFA3 is associated with susceptibility to severe sepsis in Chinese Han population. Anesthesiology 2010; 112: 1428-1434 [PMID: 20502117 DOI: 10.1097/ALN.0b013e3181d968eb]
29. Henrichsen CN, Chaignat E, Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet 2009; 18: R1-R8 [PMID: 19297395 DOI: 10.1093/hmg/ddp011]
30. Joshi MB, Lad A, Bharath Prasad AS, Balakrishnan A, Ramachandra L, Satyamoorthy K. High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation. FEBS Lett 2013; 587: 2241-2246 [PMID: 23735697 DOI: 10.1016/j.febslet.2013.05.053]
31. Fang XM, Shu Q, Chen QX, Book M, Sahl HG, Hoeft A, Stuber F. Differential expression of alpha- and beta-defensins in human peripheral blood. Eur J Clin Invest 2003; 33: 82-87 [PMID: 12492457 DOI: 10.1046/j.1365-2362.2003.01076]
32. Neuwirth A, Dobeš J, Oujezdská J, Ballek O, Benešová M, Sumník Z, Včeláková J, Koloušková S, Obermannová B, Koláø M, Stechová K, Filipp D. Eosinophils from patients with type 1 diabetes mellitus express high level of myeloid alpha-defensins and myeloperoxidase. Cell Immunol 2012; 273: 158-163 [PMID: 22248881 DOI: 10.1016/j.cellimm.2011.12.001]
33. Prado-Montes de Oca E, García-Vargas A, Lozano-Inocencio R, Gallegos-Arreola MP, Sandoval-Ramírez L, Dávalos-Rodríguez NO, Figuera LE. Association of beta-defensin 1 single nucleotide polymorphisms with atopic dermatitis. Int Arch Allergy Immunol 2007; 142: 211-218 [PMID: 17108702 DOI: 10.1159/000097023]
34. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 2003; 41: 90-96 [PMID: 12517831 DOI: 10.1128/jcm.41.1.90-96.2003]
35. Prado-Montes de Oca E, Velarde-Félix JS, Ríos-Tostado JJ, Picos-Cárdenas VJ, Figuera LE. SNP 668C (-44) alters a NF-kappaB1 putative binding site in non-coding strand of human beta-defensin 1 (DEFB1) and is associated with lepromatous leprosy. Infect Genet Evol 2009; 9: 617-625 [PMID: 19460328 DOI: 10.1016/j.meegid.2009.03.006]